Literature DB >> 10950381

Immunohistochemical localization of the VIP1 receptor (VPAC1R) in rat cerebral blood vessels: relation to PACAP and VIP containing nerves.

J Fahrenkrug1, J Hannibal, J Tams, B Georg.   

Abstract

The two structurally related peptides, vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP), are present in cerebral vascular nerve fibers. Biologic actions of VIP are exerted through two receptors, VPAC1 and VPAC2, having similar binding affinity for both VIP and PACAP. In the current study, the authors have developed a specific antibody against the rVPAC1 receptor to examine the localization of rVPAC1 immunoreactivity in cerebral arteries and arterioles of the rat by immunohistochemistry using fluorescence confocal microscopy. Specificity of the antiserum was ensured by immunoblotting and immunocytochemistry of cells transfected with cDNA encoding the different PACAP-VIP receptor subtypes. The rVPAC1 receptor immunoreactivity was localized to the plasmalemma of circularly orientated smooth muscle cells on superficial cerebral arteries and arterioles taken from the basal surface of the brain. By double immunostaining VIP immunoreactive nerve fibers and, to a lesser extent, those containing PACAP were shown to have intimate contact with the receptor protein. Vasoactive intestinal polypeptide and PACAP containing cerebrovascular nerve fibers were found in separate nerve populations with different distribution pattern and density. In brain sections processes of cortical VIP-, but not PACAP-, containing neurons seemed to innervate the rVPAC1 receptor of pial arterioles on the brain surface. The current findings provide the neuroanatomical substrate for a role of VIP and maybe PACAP in the regulation of cerebral blood flow.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10950381     DOI: 10.1097/00004647-200008000-00006

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  29 in total

1.  Mechanisms of VIP-induced inhibition of the lymphatic vessel pump.

Authors:  Pierre-Yves von der Weid; Sonia Rehal; Peter Dyrda; Stewart Lee; Ryan Mathias; Mozibur Rahman; Simon Roizes; Mohammad S Imtiaz
Journal:  J Physiol       Date:  2012-03-25       Impact factor: 5.182

2.  Cortical GABA interneurons in neurovascular coupling: relays for subcortical vasoactive pathways.

Authors:  Bruno Cauli; Xin-Kang Tong; Armelle Rancillac; Nella Serluca; Bertrand Lambolez; Jean Rossier; Edith Hamel
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

3.  Depth-resolved optical imaging and microscopy of vascular compartment dynamics during somatosensory stimulation.

Authors:  Elizabeth M C Hillman; Anna Devor; Matthew B Bouchard; Andrew K Dunn; G W Krauss; Jesse Skoch; Brian J Bacskai; Anders M Dale; David A Boas
Journal:  Neuroimage       Date:  2007-01-11       Impact factor: 6.556

4.  Pituitary Adenylate Cyclase-Activating Polypeptide Is Upregulated in Murine Skin Inflammation and Mediates Transient Receptor Potential Vanilloid-1-Induced Neurogenic Edema.

Authors:  Zsuzsanna Helyes; Jozsef Kun; Nora Dobrosi; Katalin Sándor; Jozsef Németh; Aniko Perkecz; Erika Pintér; Krisztina Szabadfi; Balazs Gaszner; Valeria Tékus; Janos Szolcsányi; Martin Steinhoff; Hitoshi Hashimoto; Dora Reglődi; Tamas Bíró
Journal:  J Invest Dermatol       Date:  2015-04-23       Impact factor: 8.551

Review 5.  Parasympathetic innervation of vertebrobasilar arteries: is this a potential clinical target?

Authors:  Eva V L Roloff; Ana M Tomiak-Baquero; Sergey Kasparov; Julian F R Paton
Journal:  J Physiol       Date:  2016-10-05       Impact factor: 5.182

Review 6.  CGRP and migraine: could PACAP play a role too?

Authors:  Eric A Kaiser; Andrew F Russo
Journal:  Neuropeptides       Date:  2013-10-23       Impact factor: 3.286

7.  Pituitary adenylate cyclase-activating polypeptide (PACAP) induces relaxations of peripheral and cerebral arteries, which are differentially impaired by aging.

Authors:  Zoltan Vamos; Ivan Ivic; Peter Cseplo; Gabor Toth; Andrea Tamas; Dora Reglodi; Akos Koller
Journal:  J Mol Neurosci       Date:  2014-06-19       Impact factor: 3.444

8.  Revisiting the role of neurons in neurovascular coupling.

Authors:  Bruno Cauli; Edith Hamel
Journal:  Front Neuroenergetics       Date:  2010-06-23

9.  VIP-targeted Cytotoxic Nanomedicine for Breast Cancer.

Authors:  Aparna Dagar; Antonina Kuzmis; Israel Rubinstein; Marin Sekosan; Hayat Onyuksel
Journal:  Drug Deliv Transl Res       Date:  2012-12-01       Impact factor: 4.617

10.  Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis.

Authors:  Varun Sethi; Israel Rubinstein; Antonina Kuzmis; Helen Kastrissios; James Artwohl; Hayat Onyuksel
Journal:  Mol Pharm       Date:  2013-01-23       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.